Metiscan Considers Becoming Apple iPhone Developer

DALLAS, TX, May 19 (MARKET WIRE) --
Metiscan, Inc. (PINKSHEETS: MTIZ), a leading provider of products and
services that streamline the management of diagnostic imaging facilities,
today announced that the Company is considering adding Apple iPhone
Development to its portfolio of products and services.

An integral part of Management's strategic plan is the intent to grow the
Company through making key acquisitions of both companies and developing
technologies prevalent in today's emerging markets. To date, the Company
has been actively involved in investing, developing, and enhancing its
core Electronic Medical (Health) Records business through its subsidiary,
Metiscan Managed Services, Inc. Already at the threshold of capitalizing
on the new multi-billion dollar stimulus package as established by
President Barack Obama, the Company is confident that continuing to
invest in medical technologies will yield a high rate of return in the
upcoming years.

In keeping with Management's overall goal and vision of investing in
emerging technologies, the Company is seeking to take advantage of the
fast growing software applications marketplace for the Apple iPhone.
"Management has been evaluating becoming an Apple iPhone Developer for
quite some time," commented Bryan A. Scott, President and CEO of Metiscan,
Inc. "We believe that the addition of the iPhone development to our
organization will allow us to further diversify our software offering and
enable us to access new revenue streams and profits. Part of the strategy
we are considering is rapid growth through acquisition of iPhone
applications with our initial focus targeted towards business related
iPhone applications."

On April 24, 2009 Apple announced that it sold its 1 Billionth iPhone
Application through its revolutionary App Store. It has been estimated
that the App Store currently features over 35,000 applications built by
thousand of developers. This summer Apple plans on releasing the iPhone OS
3.0 software update which will provide over 1,000 new APIs that will
enable countless new features for iPhone developers to take advantage of.
Applications are sold under various categories to include Business,
Finance, Entertainment, Games, Medical, and Lifestyle. Applications on
average range in price from free to $3.99+ per application. It is not
unheard of for a single developer with a single application to exceed more
than $100,000 in revenues per month.

About Metiscan, Inc.

Metiscan, Inc. is a national provider of products and services that
streamline the management and operation functions of diagnostic imaging
facilities, radiology groups, in-office imaging groups, small hospitals
and physician offices and is an operator of an MRI facility located in
Pottsville, PA. Metiscan's keystone product is a web-based radiology
information system that interfaces Radiology Information System (RIS),
Teleradiology and PACS (Picture Archiving and Communication System) for
its clients. Metiscan also provides information management and operations
support for diagnostic imaging facilities through complete revenue cycle
management, electronic health records or EHR, medical transcription
services and functional training as needed.

Safe Harbor Statement: Certain of the statements made in this press
release constitute forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Such forward-looking statements involve known and
unknown risks, uncertainties and other unknown factors that could cause
Metiscan's actual results to be materially different from the historical
results or from any future results expressed or implied by such
forward-looking statements. Statements contained in this release that are
not historical facts may be deemed to be forward-looking statements. In
addition to statements that explicitly describe such risks and
uncertainties, readers are urged to consider statements labeled with the
terms "believes," "belief," "intends," "anticipates" or "plans" to be
uncertain and forward-looking. The Company does not intend to update any
of the forward-looking statements after the date of this release to
conform these statements to actual results or to changes in its
expectations, except as may be required by law.

Investor Relations:
David Donlin
The Cervelle Group
407-614-5959

Copyright 2009, Market Wire, All rights reserved.

-0-